Abstract
Antisera were raised against peptide sequences that are normally internal in the poliovirus virion. These antisera contain neutralizing activity, but this neutralizing activity is dependent on coincubation of the virus and antisera at 37 degrees C. Immunoprecipitation analyses demonstrate that the neutralization is due to exposure of these normally internal sequences at 37 degrees C and subsequent antibody binding. Exposure of these sequences is reversible. These data demonstrate that the poliovirus particle is a dynamic entity that is capable of undergoing conformational alterations at physiological temperatures. This conformational flexibility provides an explanation for earlier observations of virus neutralization by antibodies to internal epitopes which can be accommodated within the framework of existing models for antibody-mediated neutralization of viral infectivity. Analogies between the sequences which are reversibly exposed at 37 degrees C with those which are irreversibly exposed upon receptor binding suggest that the observed conformational dynamics also may play a role in cell entry.
MeSH Terms
Antibodies, Viral
Antibody Specificity
Antigens, Viral/chemistry
Capsid/chemistry,immunology
Capsid Proteins
Epitopes/chemistry
HeLa Cells
Humans
Neutralization Tests
Poliovirus/chemistry,immunology,ultrastructure
Protein Conformation
Temperature
Chemicals
Antibodies, Viral
Antigens, Viral
Capsid Proteins
Epitopes
VP1 protein, Poliovirus
VP4 protein, Rotavirus
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Li Q
Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock 72205.
Yafal A G
Lee Y M
Hogle J
Chow M
References (23)
23 references, click to expand
-
Aspects of the synthesis of poliovirus RNA and the formation of virus particles.
Virology. 1966 Jun;29(2):179-89
PMID: 4287327
-
An immunodominant N-terminal region of VP1 protein of poliovirion that is buried in crystal structure can be exposed in solution.
Virology. 1993 Aug;195(2):762-5
PMID: 8393243
-
Inhibition of uncoating of poliovirus by arildone, a new antiviral drug.
Virology. 1979 Sep;97(2):307-15
PMID: 224584
-
Effect of arildone on modifications of poliovirus in vitro.
Virology. 1980 Aug;105(1):86-93
PMID: 6251614
-
Isolated poliovirus capsid protein VP1 induces a neutralizing response in rats.
Proc Natl Acad Sci U S A. 1982 Dec;79(23):7518-21
PMID: 6296837
-
Identification of a poliovirus neutralization epitope through use of neutralizing antiserum raised against a purified viral structural protein.
Virology. 1983 Jan 15;124(1):144-51
PMID: 6186073
-
Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies.
Proc Natl Acad Sci U S A. 1985 Feb;82(3):910-4
PMID: 2983321
-
Structure of a human common cold virus and functional relationship to other picornaviruses.
Nature. 1985 Sep 12-18;317(6033):145-53
PMID: 2993920
-
Three-dimensional structure of poliovirus at 2.9 A resolution.
Science. 1985 Sep 27;229(4720):1358-65
PMID: 2994218
-
Myristylation of picornavirus capsid protein VP4 and its structural significance.
Nature. 1987 Jun 11-17;327(6122):482-6
PMID: 3035380
-
Three-dimensional structure of poliovirus serotype 1 neutralizing determinants.
J Virol. 1988 May;62(5):1781-94
PMID: 2451757
-
The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution.
Nature. 1989 Feb 23;337(6209):709-16
PMID: 2537470
-
Mutations in VP1 of poliovirus specifically affect both encapsidation and release of viral RNA.
J Virol. 1990 Jan;64(1):195-206
PMID: 2152812
-
Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding.
J Virol. 1990 May;64(5):1934-45
PMID: 2157861
-
Antigenic structure of picornaviruses.
Curr Top Microbiol Immunol. 1990;161:121-54
PMID: 2169382
-
Host range determinants located on the interior of the poliovirus capsid.
EMBO J. 1991 May;10(5):1067-74
PMID: 1850692
-
Identification of residues in VP2 that contribute to poliovirus neutralization antigenic site 3B.
Virology. 1991 Sep;184(1):391-6
PMID: 1714663
-
Molecular characterization of mouse-virulent poliovirus type 1 Mahoney mutants: involvement of residues of polypeptides VP1 and VP2 located on the inner surface of the capsid protein shell.
J Virol. 1993 Jul;67(7):3808-17
PMID: 8389907
-
A mutation in VP4 defines a new step in the late stages of cell entry by poliovirus.
J Virol. 1993 Aug;67(8):5075-8
PMID: 8392631
-
REACTIVATION OF NEUTRALIZED VIRUS BY FLUOROCARBON: MECHANISM OF ACTION AND DEMONSTRATION OF REDUCED REACTIVABILITY WITH TIME OF VIRUS-ANTIBODY INTERACTION.
Virology. 1963 Oct;21:174-82
PMID: 14070170
-
Dissociation of poliomyelitis virus from neutralizing antibody.
Virology. 1958 Aug;6(1):297-9
PMID: 13581538
-
Reversibility of the reaction between polio-virus and neutralizing antibody of rabbit origin.
Virology. 1961 Jul;14:316-28
PMID: 13766052
-
An analysis of the physical and chemical factors involved in the reactivation of neutralized poliovirus by the method of freezing and thawing.
Virology. 1973 Feb;51(2):358-69
PMID: 4348304